Table 2 IC50 of SNRPD1 or SNRPE silenced cells in response to doxorubicin treatment in triple negative breast cancer cells. ‘Gene’ shows the gene targeted by siRNA. ‘IC50’ and ‘SE’ each lists the estimate and standard error of the IC50 values. The p-value shows the significance of the difference between siRNA transfected and control cells in each cell line

From: SNRPD1 conveys prognostic value on breast cancer survival and is required for anthracycline sensitivity